Authors
Tianrui Chang, Cheng Jiang, Shijun Yan, Shofarul Wustoni, Luca Salvigni, Rania Almaghrabi, Michele T Hu, George K Tofaris, Keying Guo, Sahika Inal
Published in
Science advances. Volume 12. Issue 40. Pages eaee4525. Oct 02, 2026. Epub Sep 30, 2026.
Abstract
Misfolded alpha-Synuclein (α-Syn) accumulation is the defining molecular pathology of Parkinson's disease (PD), yet blood-based assays remain challenged by the high background of peripheral α-Syn originating mainly from red blood cells. Neuronal extracellular vesicles (EVs) circulating in blood offer a biologically enriched source of brain-derived α-Syn proteoforms, but their ultralow abundance has hindered reliable detection. Here, we introduce an organic electrochemical transistor-based multiparametric diagnostic assay that simultaneously detects total, aggregated, and serine-129-phosphorylated α-Syn proteoforms in serum L1CAM+ EVs. The platform achieves low femtomolar sensitivity in buffer and robust analytical performance in clinical specimens. In a cohort of 66 individuals, including prodromal and clinically diagnosed patients with PD, combining the three proteoform readouts distinguished PD from controls with 90.9% accuracy (88.6% sensitivity and 90.9% specificity). By electronically amplifying and resolving multiple neuronal α-Syn signatures in blood, this assay enables a minimally invasive diagnostic tool for early-stage PD and provides a path toward therapeutic intervention during the window when disease-modifying treatments are likely to be most effective.
PMID:
42814818
Bibliographic data and abstract were imported from PubMed on 01 Oct 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 34
- Comments 0